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Abstract
Background
Perioperative fluid restriction in a variety of operations has shown improvement of: compli-
cations, recovery of gastrointestinal function and length of stay (LOS). We investigated
effects of crystalloid fluid restriction in pancreatic surgery. Our hypothesis: enhanced recov-
ery of gastrointestinal function.
Methods
In this double-blinded randomized trial, patients scheduled to undergo pancreatoduode-
nectomy (PD) were randomized: standard (S:10ml/kg/hr) or restricted (R:5ml/kg/hr) fluid
protocols. Primary endpoint: gastric emptying scintigraphically assessed on postoperative
day 7.
Results
In 66 randomized patients, complications and 6-year survival were analyzed. 54 patients
were analyzed in intention to treat: 24 S-group and 30 R-group. 32 patients actually under-
went a PD and 16 patients had a palliative gastrojejunostomy bypass operation in the full
protocol analysis. The median gastric emptying time (T½) was 104 minutes (S-group,
95% confidence interval: 74–369) versus 159 minutes (R-group, 95% confidence interval:
61–204) (P = 0.893, NS). Delayed gastric emptying occurred in 10 patients in the S-group
and in 13 patients in the R-group (45% and 50%, P = 0.779, NS). The primary outcome
parameter, gastric emptying time, did not show a statistically significant difference
between groups.
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Conclusion
A fluid regimen of 10ml/kg/hr or 5ml/kg/hr during pancreatic surgery did not lead to statisti-
cally significant differences in gastric emptying. A larger study would be needed to draw def-
inite conclusions about fluid restriction in pancreatic surgery.
Trial registration
ISRCTN62621488
Introduction
Perioperative fluid restriction can enhance recovery of gastrointestinal function, reduce com-
plications and also hospital stay in patients subjected to a variety of abdominal surgical proce-
dures [1–6]. This beneficial effect of fluid restriction is due to a decrease in visceral and
interstitial edema caused by crystalloids infusion during surgery [7–9]. The timing of the fluids
is essential to the outcome of surgery [10]. A study in colorectal surgery demonstrated a lack of
effect on length of stay, while reducing complications [11]. Other studies however, focusing on
other types of surgery, failed to report beneficial effects of fluid restriction [4, 12, 13]. A recent
meta-analysis concluded that perioperative fluid restriction does not reduce complications or
length of hospital stay [14]. Most studies concerning fluid restriction use inaccurate definitions,
“restricted” ranging from 4 to 9 ml/kg/hr and “liberal” from 9 to 18 ml/kg/hr. Great variation
exists in composition of fluids and other measures used: glucose 5%, saline 0.9%, saline 0.18%
+ dextrose 4%, Ringers Lactate, starch, furosemide for weight control etcetera [8, 15, 16]. This
effect of fluid restriction has not been studied in pancreatic surgery, although a study on acute
normovolemic hemodilution (ANH) in pancreatoduodenectomy (PD) found more anasto-
motic complications in the ANH-group—a finding which, according to the authors, could be
explained by the associated greater fluid administration in this study arm [17]. A recent (retro-
spective) study of patients after pancreatic resection found no significant correlation between
complications and the intraoperative amount of fluids [18]. A procedure-specific approach,
with procedure-specific endpoints, is necessary to determine the best method of perioperative
fluid management for each surgical procedure [8, 19].
Many trials have compared the difference in clinical outcome between restricted and liberal
fluid regimens perioperatively. To separate effects of postoperative restriction and intraopera-
tive restriction different kinds of trials are needed. An earlier trial in our hospital concerning
fluid restriction in the postoperative phase after major abdominal surgery was discontinued
because of a significantly higher number of complications in the fluid restricted group [20].
Surgical handling combined with fluid overload could have its maximal effect in the intrao-
perative phase, which is the reason we conducted this randomized controlled trial focusing on
fluid restriction intraoperatively. The aim of this study was to show the effect of a restricted,
intraoperative crystalloid fluid protocol on gastric emptying, postoperative complications and
duration of hospital stay, as compared to our standard intraoperative fluid protocol, in patients
with a suspected pancreatic tumor, undergoing an exploration for resection. Our hypothesis
was that intraoperative crystalloid fluid restriction would have a beneficial effect on gastric
emptying, analogous to an earlier study by Lobo and co-authors [3].
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Materials and Methods
Study design and patients
The study was designed as a prospective, double blinded, single center randomized controlled
trial (EPOR trial, ISRCTN62621488), for which approval of the AMCMedical Ethics Commit-
tee was obtained. (S1 Protocol) Written informed consent was obtained from all participating
patients. The setting was at the Academic Medical Center/University of Amsterdam, in
Amsterdam, The Netherlands. All operations were performed by a selected team of 3 experi-
enced hepato-pancreato-biliary surgeons, who performed at least 100 pancreatic resections on
annual basis.
Inclusion criteria for study participation were: scheduled to undergo pancreatoduodenect-
omy (PD) for a suspected pancreatic head or periampullary tumor, age>18 years and Ameri-
can Society of Anesthesiologists (ASA) classification I-IV. Exclusion criteria were: diabetes
mellitus, renal failure, drug or alcohol abuse, clinical signs of preoperative gastroparesis, unfit
to participate due to language or psychiatric problems, contraindications for epidural (such as
severe coagulation disorder), blood loss of more than 50% of circulating volume and/or postop-
erative ICU, or participation in another clinical trial. Patients were also excluded from further
analysis in the case of preoperative or early intraoperative protocol violation: for example when
during the operation no (pylorus preserving) PD or gastric bypass was performed, or in case of
failure of epidural catheter placement, to minimize the effect of postoperative intravenous opi-
ates on gastric emptying.
Time period of inclusion was: 1st May 2006 to 1st March 2009. Follow-up time was planned
for at least a year. Inclusion of the patients was done preferably at least 7 days before the
planned operation date by a researcher not involved with the study, giving patients reasonable
time to think about participation. An epidemiologist provided a computer generated randomi-
zation chart on paper, which was kept by a researcher not involved with the study, and checked
by an independent noninvolved researcher. Participating patients were randomly assigned (1:1
ratio) to either a restricted or a standard intraoperative fluid management. Neither the anesthe-
siologist nor the operating surgeon was aware of the randomization group, until the comple-
tion of the entire study. This was achieved by a covered volumetric infusion pump, with
crystalloid infusion fluid rate set by a research assistant. Under an opaque black plastic clothes
bag, five bags of 500 ml were connected to each other, containing Ringers Lactate, totaling
2500 ml, and in turn connected to an infusion pump as above. This was repeated if necessary
by an independent researcher, if the infusion pump was almost empty during the procedure.
That way, the amount of intravenous fluids was not known to the anesthesiologist, who only
administered extra colloids, red blood cells and medication as indicated in protocol (blood loss
was compensated in equal volume by colloid infusion in both groups, red blood cells were
given when hemoglobin values decreased below 5.0 mmol/l).
Study procedures. Antithrombotic and antibiotic prophylactic medication (intravenous
cefuroxime and clindamycin) was administered in all patients. No prophylactic prokinetic
drugs were given. The intended standard surgical procedure was a pylorus-preserving PD with
removal of lymph nodes at the right side of the portal vein, as described earlier [21]. 32 patients
actually underwent a PD. 16 patients underwent a palliative bypass procedure; these were
included in the analysis. Patients who did not undergo either PD or palliative bypass were
excluded from analysis. In our study these patients were: 2 patients with bile duct resection, 1
patient with a benign pancreatic cyst, 1 patient with pancreatic corpus tumor, and in 1 patient
we were unable to perform even a palliative bypass (“open-close surgery”).
Anesthesiological management included a thoracic (T7-T8 or T8-T9) epidural catheter.
Epidural infusion consisted of bupivacaine 0.25% with sufentanil 0.5 microgram per ml at a
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speed of 8–10 ml per hour in both groups. In case of a failed placement of the epidural catheter,
patients received intravenous patient controlled analgesia (PCA) with morphine postopera-
tively and were excluded from further study participation due to the influence of morphine on
gastric emptying. FiO2 was 60%.[22, 23] If mean arterial pressure (MAP) was 20% below
baseline, norepinephrine (standard dose: 1–4 μg/kilogram body weight/hr) was used (in the
absence of blood loss) to keep MAP at +/- 20% of its baseline value. Isoflurane was used in
both groups at endtidal concentrations of 1 MAC (age corrected minimum alveolar
concentration.)
Fluid management. Standard and restricted fluid infusions (S group and R group) con-
sisted of 10 ml/kg/hr (S) and 5 ml/kg/hr (R) Ringer’s Lactate. This was an arbitrary decision,
based on earlier studies intraoperative fluid administration in abdominal surgery [24, 25].
With a predicted average operating time of 6 hours, this would be 4800 ml or 2400 ml respec-
tively in a patient of 80 kg.
All patients were monitored overnight in the post anesthesia care unit (PACU) and were
discharged to the surgical ward the following day. Post-operative fluid management was stan-
dardized and similar in both groups. Differences between groups in fluid administration were
only in the intraoperative period. The total daily fluid intake was set at 2500 ml/24 hrs, includ-
ing any oral intake, with correction for nasogastric and other drain loss. The nasogastric drain
was removed if production was below 300 ml/24 hrs.
Outcome measures. The primary outcome measure was gastric emptying time (i.e. reduc-
tion of minutes needed to achieve a 50% emptying of the stomach), as measured by scintigra-
phy with a solid test meal on the seventh postoperative day. Secondary outcome parameters
included postoperative surgical complications, including the incidence of delayed gastric emp-
tying (DGE) according to the definition of the International Study Group of Pancreatic Surgery
(ISGPS), relaparotomy rate, non-surgical complications, mortality, duration of hospital stay,
values of urea, creatinine, albumin, remaining length of duodenum and body weight [26]. We
had originally planned to include nutritional intake (kCal/day) as well, but had to exclude this
parameter because of the lack of possibilities of the nursing department to document this par-
ticular parameter in a detailed way.
Solid phase scintigraphy was performed on two days: 1. On the day preceding the operation,
to establish a baseline measurement. 2. On the seventh postoperative day, using a small size
75-gram pancake labeled with 10 MegaBecquerel technetium 99m colloid, with a caloric con-
tent of 576 kJ (137 kCal), containing 70% carbohydrates, 14% protein, and 16% fat. Patients
ingested at least 75% of the meal with a glass of water within 5 minutes (min). Patients did not
receive any prokinetic drugs 24 hours prior to the gastric emptying examination [27].
Sample size. A difference in gastric emptying time of 30 min between the study groups
was considered as statistically significant, as normal solid phase emptying has been shown to
fall in the range of approximately 60 min in volunteers [3, 28]. We calculated that 22 patients
in each group would have 90% power to detect a difference in mean emptying time of 30 min,
assuming that the common standard deviation was 33 min and using a two-group Student’s t-
test with a 0.05 one-sided significance level.
Statistical analysis. All clinically relevant outcome measures were analyzed by the inten-
tion-to-treat principle. Gastric emptying was only analyzed in patients who underwent gastric
emptying scintigraphy (per-protocol population). Data are described as means with standard
deviation or medians with interquartile ranges where appropriate. Continuous data were ana-
lyzed by the Student’s t-test or Mann-Whitney U test, depending on the distribution of the
data. The Chi-square test or Fisher’s exact test (in case of zero cell counts) was used to compare
categorical data. A P-value below 0.05 was considered statistically significant. All analyses were
performed with SPSS Version 22.0 (SPSS Inc., Chicago, IL, USA).
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Results
Trial profile
The trial profile is shown in the trial flow chart (Fig 1). We randomized 66 patients. In the stan-
dard group 32 patients were allocated. Of these, 2 had a failed epidural. In 5 patients a different
operation was performed than originally planned (not a pancreatoduodenectomy or bypass).
In 1 patient, there was massive blood loss at an early stage during the operation, resulting in
loss of more than 50% of circulating volume, and making it impossible to follow protocolled
fluid infusion. We excluded these patients. We allocated 34 patients to the restricted group. In
the restricted group, 1 patient had a failed epidural. In 3 patients, the final operation differed
from the planned one (not a pancreatoduodenectomy or bypass). The above resulted in 54
patients (24 patients in the S group, 30 in the R group) to be analyzed in the intention-to-treat
analysis. Complications and 6-year survival are analyzed for 66 patients. In the standard group,
2 patients refused scintigraphy in the postoperative phase. In the restricted group, 1 patient
refused scintigraphy, and 3 patients were unable to complete the protocol (second scan) due to
logistic reasons (scanning machine was unavailable due to repairs). Postoperative scans were
therefore only done for 48 patients. This resulted in 48 patients (22 patients in the S group, 26
in the R group) in the per-protocol analysis. After the initial completion of the calculated 44
patients, we obtained permission from the ethics committee to recruit additional patients, to
reach the number of 54 included patients, because dropouts had resulted in an unequal distri-
bution between groups, resulting in a number lower than required by the power calculation, in
one of the groups. (S1 File) The infusion system enabling simultaneous connection of 5 infu-
sion bags is shown below. (Fig 2.)
Patient and treatment characteristics
There were no differences between both groups in age, gender, weight, ASA classification or
underlying disease.
Treatment characteristics are shown in Table 1. The mean amount of intraoperative crystal-
loids infusion was 9.8 ml/kg/hour in the S group, and 5.1 ml/kg/hour in the R group, indicating
that the randomization and protocol had been followed properly. The mean amount of colloid
administration was 1 liter in the S group, and 1.4 liters in the R group (P = 0.029). Norepineph-
rine dose, blood loss and intraoperative diuresis were similar in both groups. The cumulative 5
day fluid balance includes oral fluid intake, and shows similar balances in both groups. Weight
increase was slightly higher in the standard group, but this difference was not significant. Both
groups showed a substantial decrease in serum albumin on postoperative day 5, without any
significant differences between groups. Creatinine and urea levels showed comparable
decreases in both groups.
Gastric emptying scintigraphy (primary endpoint)
The preoperative gastric emptying scans were performed on the day preceding the operation.
The distribution of all gastric emptying times showed a skewness of 1.027, making it highly
skewed. We have split these preoperative scans into two groups in the table, even though it was
not known at the time of scanning which group the patients would be allocated to. Postopera-
tive scans: 48 Patients underwent a gastric scintigraphy on the seventh postoperative day
(Table 2). The postoperative gastric emptying times were also not normally distributed: the
Shapiro Wilk test showed a difference between a normal distribution and our data with a sig-
nificance of<0.001, so therefore we calculated difference in medians instead of the planned
mean differences in emptying times between groups. The assumed common standard deviation
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Fig 1. Trial flow chart.
doi:10.1371/journal.pone.0140294.g001
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(SD) of 33 minutes turned out to be higher: SD of 143 (standard group) and SD of 137 (restric-
tive group). The median gastric emptying time (T½) was 104 minutes (S-group, 95% confi-
dence interval: 74–369) versus 159 minutes (R-group, 95% confidence interval: 61–204)
(P = 0.893, NS). The differences in our primary endpoint are not significant. (Table 2). The
number of patients who were judged to have a delay in gastric emptying, based on consensus
recommended gastric emptying scintigraphy normal range criteria, was 10 (45%) in the S
group and 13 (50%) in the R group (P = 0.779, NS) [29]. The median percentage of radioactiv-
ity remaining in the stomach after 120 minutes (% RA 120) was 47 in the S group (95% confi-
dence interval: 30–94) and 64 in the R group (95% confidence interval: 35–91) (P = 0.852, NS).
The primary outcome parameter (gastric emptying time) did not show a statistically significant
difference between groups.
When analyzing only those patients who underwent a PD, the median T½ was 193 minutes
in the S group (95% confidence interval: 77–372) and 165 minutes in the R group (95% confi-
dence interval: 61–274) (P = 0.558, NS). In the S group, 7 patients (58%) had delayed gastric
emptying according to consensus recommended scintigraphy criteria, compared to 11 (55%)
in the R group (P = 0.854, NS). The median % RA 120 was 84% in the S group (95% confidence
interval: 40–95) and 80% in the R group (95% confidence interval: 35–95) (P = 0.906, NS). The
primary outcome parameter (gastric emptying time) did not show a statistically significant dif-
ference between groups.
Delayed gastric emptying
The incidence of delayed gastric emptying (DGE) according to the criteria of the ISGPS is
shown in Table 3. There were no significant differences between both groups in the incidence
of the DGE of any grade, the distribution among the different grades or the incidence of clini-
cally relevant DGE (grade B or C).
Other complications
Complications other than DGE are shown for 66 patients in Table 4. Overall morbidity rates in
the S and R groups were 47% and 62%, respectively (P = 0.32). There were no significant differ-
ences between the groups in surgical complications, relaparotomy rate or mortality. Non-surgi-
cal complications occurred in 3 patients (9%) in the S group, and in 8 patients (24%) in the R
Fig 2. Connection piece. Cyto Set system enabling simultaneous use of 5 infusion bags.
doi:10.1371/journal.pone.0140294.g002
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group. Cardiopulmonary complications occurred more often in the R group as compared to
the S group (5 (15%) versus 1 (3%). However, this difference was not significant (P = 0.20). In
the R group, three patients had pneumonia, there was one case of pulmonary embolism and
one case of cardiac failure. In the S-group, one patient had a cardiac arrest.
Table 1. Treatment characteristics of 54 patients who underwent PPPD or palliative bypass procedure, and were randomized to the Standard or
Restricted group. Data shown include fluid infusion data during the procedure, and i.v.* noradrenalin and diuresis at the end of operation.
Endpoint Standard (max N = 24) Restricted (max N = 30) P-value
Operation—No. (%)
Resections: 0.08
Pylorus preserving PD 13 (54) 23 (77)
Palliative procedures:
Bypass procedure with GJ 11 (46) 7 (23)
Duration of procedure in minutes 248 (104) [210–288] 289 (78) [262–316] 0.101
Blood loss in liters** 1.0 (0.8) [0.6–1.3] 1.1 (0.6) [0.9–1.4] 0.393
Actual crystalloids during operation in ml/kg/hour† 9.8 (1.1) [9.3–10.2] 5.1 (0.3) [5.0–5.2] <0.001
Actual crystalloids during operation in liters† § 2.5 (1.7–3.6) [2.0–3.4] 2.0 (1.4–2.4) [1.6–2.2] 0.013
Actual crystalloids during PPPD in liters# § 3.4 (2.5–6.0) [2.7–4.9] 2.1 (1.6–2.5) [1.8–2.4] <0.001
Colloids during operation in liters† 1.0 (0.6) [0.8–1.3] 1.4 (0.6) [1.2–1.6] 0.029
Plasma during operation in ml 108 (367) [45–271] 195 (423) [70–337] 0.432
Noradrenalin i.v.* in micrograms /kg /min˄ 0.04 (0.03) [0.03–0.05] 0.05 (0.05) [0.03–0.07] 0.388
Intraoperative diuresis in ml /kg /hr˄˄ 1.9 (1.2) [1.5–2.4] 1.5 (1.1) [1.2–2.0] 0.195
Cumulative 5 day ﬂuid balance˜ 5.5 (4.2) [3.5–7.7] 4.6 (3.4) [3.0–6.2] 0.495
Increase in weight on day 5ǂ (in Kg) 5.0 (3.4) [3.3–6.5] 3.5 (3.0) [2.3–4.6] 0.180
Preoperative serum albumin (mmol/l) $ 44 (3.9) [42–45] 43 (3.5) [41–44] 0.399
Albumin, on 5th postoperative day (mmol/l) $$ 30 (3.0) [29–31] 30 (3.9) [28–31] 0.644
Preoperative creatinine (mmol/l) & 67 [62–73] 71 [65–77] 0.329
Creatinine, on 5th postoperative day (mmol/l) &* 58 [57–59] 61 [56–65] 0.311
Preoperative serum urea (mmol/l) && 5.3 [4.3–6.4] 5.6 [5.1–6.3] 0.330
Serum urea on 5th postoperative day (mmol/l) &&& 3.5 [3.2–3.7] 3.7 [2.9–4.7] 0.339
Remaining length of duodenum in cm## 1.4 (1.4) [0.8–2.0] 2.3 (1.6) [1.7–2.8] 0.05
Values are shown as mean, (SD), (1st Quartile-3rd Quartile), [Bias-corrected 95% conﬁdence interval] unless otherwise speciﬁed.
* i.v., intravenous;
**N: 22 versus 28;
† N: 24 versus 29;
§ median and interquartile range;
#N:13 versus 23;
˄N: 22versus 27;
˄˄N: 24 versus 28;
˜N: 14 versus 16;
ǂ, N = 14 versus 19;
$, N = 19 versus 25;
$$, N = 21 versus 23;
& median, N = 22 versus 26;
&*, N:21 versus 24;
&&, N = 20 versus 23;
&&&, N = 21 versus 24;
##, N = 21 versus 25.
doi:10.1371/journal.pone.0140294.t001
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Follow-up
We had planned follow-up for at least a year. We recently verified the status of all randomized
patients, to check for survival and possible differences between groups. This was done in
August 2015, and offers a six year follow-up concerning survival. (Table 5, Fig 3)
Discussion
This study was performed to investigate the effect of intraoperative crystalloid fluid restriction
on postoperative gastric emptying in patients undergoing pancreatic surgery. Our findings
were that implementation of a restricted crystalloid fluid protocol during surgery of 5 ml/kg/hr
did not affect gastric emptying time on postoperative day (POD) 7, compared to the standard
Table 2. Results of scintigraphy performed preoperatively and 7 days postoperatively in 48 full protocol patients who underwent PPPD or pallia-
tive bypass procedure and were randomized to a Standard or a Restricted fluid protocol. The second part specifies 32 patients who only under-
went a PPPD procedure and were randomized to a Standardized or a Restricted fluid protocol.
Per-protocol population PPPDs, per-protocol population
Standard
(N = 22)
Restricted
(N = 26)
P
value
Standard
(N = 12)
Restricted
(N = 20)
P-
value
T½*—Median, [CI]^^ Preoperative values 40 [33–57] 45 [36–50] 0.619
T½*—Median, (IQR†) [CI]^^ Postoperative values 104 (71–370)
[74–369]
159 (57–346)
[61–204]
0.893 193 (74–372)
[77–372]
165 (56–361)
[61–274]
0.558
Delayed gastric emptying by scintigraphic criteria—
No. (%) [Conﬁdence interval]§
10 (45) [27–65] 13 (50) [32–68] 0.779 7 (58) [32–81] 11 (55) [34–74] 0.854
% RA 120‡—Median, (IQR) [CI]^^ 47 (28–95) [30–
94]
64 (25–96) [35–
91]
0.852 84 (25–99) [40–
95]
80 (24–100) [35–
95]
0.906
* T½, time in minutes needed to empty half of the gastric content.
† IQR, inter quartile range.
^^CI, bootstrap based bias-corrected 95% conﬁdence interval;
§ Conﬁdence intervals calculated using by the modiﬁed Wald method: p’ = S+2/n+4 W = 2
p
p’(1-p’)/n+4; CI = p’- W to p’+W. Graphpad software.
‡ % RA 120, percentage of radioactivity remaining in the stomach after 120 minutes of emptying.
doi:10.1371/journal.pone.0140294.t002
Table 3. Distribution of clinical delayed gastric emptying of 54 patients who underwent PPPD* or pal-
liative bypass procedure with GJ† and were randomized between a Standard or a Restricted intrao-
perative fluid protocol.
Standard (N = 24) Restricted (N = 30) P-value
ISGPS‡ grade No. (%)
No DGE§ 12 (50) [31.4–68.6] 17 (57) [39.2–72.7] 0.524
Grade A 2 (8) [1.2–27] 3 (10) [2.7–26.4]
Grade B 7 (29) [14.7–49.4] 4 (13) [4.7–30.3]
Grade C 3 (13) [3.5–31.8] 6 (20) [9.1–37.7]
*PPPD, Pylorus-preserving pancreatoduodenectomy;
†GJ, gastrojejunostomy;
‡ ISGPS, International Study Group of Pancreatic Surgery.
§ DGE, delayed gastric emptying. Delayed gastric emptying Grade A, B and C in increasing severity,
(Surgery 2007; 142(5):761–768). Values shown as N, (%) and [95% conﬁdence interval]. Conﬁdence
intervals were calculated using by the modiﬁed Wald method: p’ = S+2/n+4 W = 2
p
p’(1-p’)/n+4; CI = p’- W
to p’+W. Graphpad software.
doi:10.1371/journal.pone.0140294.t003
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crystalloid fluid implementation of 10 ml/kg/hr. No differences in secondary outcome parame-
ters, such as other complications, fistula rate, relaparotomy rate or mortality, were found. The
latter results have to be considered explorative, as the sample size refers to gastric emptying.
The sample size was based on an assumption which later proved to be incorrect: we assumed a
normally distributed normal gastric emptying of 60 minutes with a common standard devia-
tion of 33 minutes (between groups) based on earlier (volunteer) studies, but our preoperative
gastric emptying scans showed a not normal distribution, and our median postoperative gastric
emptying times had a very wide 95% confidence interval. Even if the difference in median
Table 4. Perioperative outcomes of 66 patients randomized between a Standard or Restricted intraoperative fluid protocol, who underwent PD* or
palliative bypass procedure with GJ†.
Standard (N = 32) Restricted (N = 34) P-value
Any complication—No. (%) [CI]~ 15 (47) [31–64] 21 (62) [45–76] 0.32
Surgical complications No. (%) [CI]
Any surgical complication 15 (47) [31–64] 20 (59) [42–74] 0.46
Pancreatic ﬁstula‡ 4 (13) [4–29] 8 (24) [12–40] 0.34
Postpancreatectomy hemorrhage‡ 3 (9) [2–25] 2 (6) [1–20] 0.67
Hepaticojejunostomy leakage 3 (9) [2–25] 1 (3) [0–16] 0.35
Wound infection 5 (16) [6–32] 7 (21) [10–37] 0.75
Other 2 (6) [1–21] 5 (15) [6–31] 0.43
Non-surgical complications No.(%) [CI]
Any non-surgical complication 3 (9) [2–25] 8 (24) [12–40] 0.19
Cardiopulmonary 1 (3) [0–17] 5 (15) [6–31] 0.20
Urogenital 2 (6) [1–21] 3 (9) [2–24] 1
Other 2 (6) [1–21] 5 (15) [6–31] 0.43
Other outcomes
Relaparotomy—No. (%) 2 (6) [1–21] 2 (6) [1–20] 1
Hospital mortality—No. (%) 1 (3) [0–7] 1 (3) [0–16] 1
Length of hospital stay in days—Median [CI]#§ 10 [9–17] 12 [11–14] 0.58
*PD, pancreatoduodenectomy;
†GJ, gastrojejunostomy; Fisher exact test.
~ [CI],Conﬁdence intervals calculated by the modiﬁed Wald method: p’ = S+2/n+4 W = 2
p
p’(1-p’)/n+4; CI = p’- W to p’+W. Graphpad software.
‡ Grade B or C according to the International Study Group of Pancreatic Surgery classiﬁcation;
# N: 31 versus 33,
§Bootstrap based bias-corrected 95% conﬁdence interval, Kruskal-Wallis test.
doi:10.1371/journal.pone.0140294.t004
Table 5. Six year follow-up regarding survival in of 66 patients randomized between a Standard or Restricted intraoperative fluid protocol, who
underwent PD* or palliative bypass procedure with GJ†.
Standard (N = 32) Restricted (N = 34) Total N P value
Died No (%) [CI]~ 19 (59) [42–74] 17 (50) [34–66] 36 0.47
Alive No (%) [CI]~ 6 (19) [9–36] 9 (26) [14–43] 15 0.56
Unknown No (%)[CI]~ 7 (22) [11–39] 8 (24) [12–40] 15 1
Total 32 34 66
*PD, pancreatoduodenectomy;
†GJ, gastrojejunostomy;
~ [CI],Conﬁdence intervals calculated by the modiﬁed Wald method: p’ = S+2/n+4 W = 2
p
p’(1-p’)/n+4; CI = p’- W to p’+W. Graphpad software.
doi:10.1371/journal.pone.0140294.t005
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gastric emptying times between groups was higher than 30 minutes, the sample size was not
sufficient because of these results.
Randomization and blinding: our randomization was done using a computer generated list
by the epidemiologist, with proper documentation and double checking of records by two inde-
pendent researchers. In addition, the implementation of blinding during the operation, fol-
lowed by blinding until the end of the study, led to heated discussions when in doubt for safety
of the patients: for instance, when patients do not produce diuresis postoperatively (even tem-
porarily), or for that matter, show any problem whatsoever, it is very difficult to convince the
attending physician to adhere to the protocols of the trial. For this reason, we monitored blood
levels of urea and creatinine, but found no significant differences between groups. Further, we
should have only included the actual pancreatoduodenectomy patients. That would have cre-
ated a more homogenous group. Without blinding, we would have had more knowledge about
the distribution of patients between the two groups.
Various studies have shown a positive effect of crystalloid fluid restriction. However, not all
studies demonstrate this positive effect, and warrant caution [20, 30]. Conflicting results of
studies on fluid restriction could be explained by a lack of consensus about restricted fluid pro-
tocols, the use of fast track protocols and by the varying endpoints that were studied [12, 13,
30, 31]. The definition of restriction, when it should be applied, and which fluids must be used
Fig 3. Kaplan Meier curve of cumulative survival. 6-year follow-up after operation, 66 patients randomized between a Standard or Restricted
intraoperative fluid protocol. Data of 15 patients are not included (unknown status). Date of death unknown for 2 patients in standard group.
doi:10.1371/journal.pone.0140294.g003
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are still under debate. In the present study, we chose to individualize the pragmatic restricted
fluid protocol based on the patient’s body weight. The primary endpoint, gastric emptying
time, was based on the findings of the above-mentioned studies, which found a beneficial effect
of restriction on the recovery of gastrointestinal function [3]. We chose this endpoint for sev-
eral reasons. At first, to show a significant influence on a parameter with low incidence such as
mortality (3% in our hospital), we would have to include an enormous amount of patients. Sec-
ondly, a substantial part of perioperative morbidity, such as pancreatic fistula, abdominal fluid
collection, hemorrhage, and anastomotic leakage, directly or indirectly leads to gastric empty-
ing problems.
We did not find beneficial effects of fluid restriction on gastric emptying, neither clinically
nor in scintigraphy studies. An explanation is that fluid restriction was limited to the intra-
operative phase, and that the difference in fluids was too small to result in differences in out-
come (during PPPD: S group 3.4 liters vs. R group 2.1 liters, Table 1). Randomization in combi-
nation with unexpected palliative procedures had led to overrepresentation of pylorus
preserving pancreatoduodenectomy (PPPD) in the restricted fluid group (23 restricted vs 13
standard). The PPPD has a much longer operation time than the palliative procedures. When
these patients receive less fluid, the total amount of fluid approximates that of a palliative pro-
cedure which is twice as short but gets twice the amount of fluid, if allotted to the standard
group. That is the reason why a greater difference is absent between the actual amounts of fluid
given in the two groups, during the operation. MacKay and co-authors also reported no differ-
ences in outcome between two different intraoperative fluid regimens [4]. We arbitrarily chose
5 and 10 ml/kg/hr for this patient group, based on our current practice and information from
earlier studies [24]. Fluid load and morbidity risk has the shape of a U-curve, meaning that risk
is lowest in the middle [25]. We would probably have found differences if the fluid regimens
were more extreme, but at the cost of patient safety.
Our study has some limitations. The assessment of 200 potential patients resulted in 66 ran-
domized patients, of which 54 could finally be included in analysis of results in Table 1. Further-
more, the sample size is relatively low reflecting the difficulty to perform such a randomized
trial. The exclusion of patients participating in other trials also is a limitation of this study. For
the primary endpoint (gastric emptying), a sample size calculation was performed assuming a
normal distribution. However, the measured gastric emptying times were not normally distrib-
uted, making the difference of 55 minutes between groups not significant. Thus, we are not yet
convinced that a restricted intraoperative fluid protocol has positive effects (on gastric emptying
time) in these patients. Secondly, the proportion of patients undergoing PD or palliation with
GJ differed between the two study groups: 54% of patients underwent PD in the S group, versus
77% in the R group. This may have influenced the results based on selection, and certainly
makes interpretation more difficult. However, in our additional, tentative subgroup analysis of
patients undergoing PD, we also did not observe differences in gastric emptying time.
Our study is the first to investigate the effect of intraoperative fluid restriction in this partic-
ular patient group, in a randomized, double blinded fashion. The fluids were administered
according to weight of the patients, without the use of transesophageal Doppler or monitoring
of stroke volume variation, in a design resembling common practice in most hospitals. As
there are no randomized controlled trials including the entire intra- and postoperative period,
which demonstrate superiority of goal directed infusion therapy over plain restriction, we
believed this to be the best approach at the time the trial was conducted [32–34]. Furthermore,
in a recent study, goal directed therapy was of no value within an enhanced recovery protocol
incorporating fluid restriction [35]. Nevertheless, this is a limitation of this study.
The primary outcome measure was determined by gastric emptying scintigraphy, which is
an objective, validated method to assess gastric emptying time even in the postoperative period
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of pancreatic surgery. The homogenous population of patients all planned to undergo the same
procedure, makes results specific to this group.
Conclusion
In the present study, no significant differences in (delayed) gastric emptying or other complica-
tions were found between standard or restrictive fluid management. However, a larger study
would be needed to draw definite conclusions about fluid restriction in pancreatic surgery.
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